ArticleSkin Lesions in Patients Treated With Imatinib Mesylate: A 5-Year Prospective StudyAuthor:Ugo Bottoni, PhDPublish date: June 7, 2016Imatinib mesylate (IM) represents the first-line treatment of patients with chronic myeloid leukemia (CLM) or gastrointestinal stromal tumor (GIST)...Read More
